Full Text
Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda

Abstract

Authors

R. Macaulay

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×